Oxidative modification of low density lipoprotein in normal and hyperlipidemic patients: Effect of lysophosphatidylcholine composition on vascular relaxation

Journal of Lipid Research

Volumn 38, Issue 3, 1997, Pages 546-553

  Chen, Li ^a   Liang, Binhua ^a   Froese, Douglas E ^a   Liu, Songyan ^a   Wong, Jason T ^a   Tran, Khai ^a   Hatch, Grant M ^a   Mymin, David ^a   Kroeger, Edwin A ^a   Man, Ricky Y K ^a   Choy, Patrick C ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

endothelium vascular; hyperlipidemia; LDL metabolism; lysophosphatidylcholine metabolism

Indexed keywords

LOW DENSITY LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE;

ACETYLATION; ANIMAL CELL; ARTERY WALL; ARTICLE; CELL TRANSFORMATION; CHOLESTEROL BLOOD LEVEL; DRUG EFFECT; DRUG RECEPTOR BINDING; FOAM CELL; HYPERLIPIDEMIA; LIPID COMPOSITION; LIPOPROTEIN METABOLISM; MACROPHAGE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASODILATATION;

ADULT; ANIMALS; AORTA; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERLIPIDEMIAS; LIPIDS; LIPOPROTEINS, LDL; LYSOPHOSPHATIDYLCHOLINES; MALE; MIDDLE AGED; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; OXIDATION-REDUCTION; RATS;

EID: 14444269481     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Brown, M. S., and J. L. Goldstein. 1976. Receptor-mediated control of cholesterol metabolism. Science. 191: 150-154.
2. Farmer, J. A., and A. M. Gotto, Jr. 1992. Risk factors for coronary artery disease. In Heart Disease (4th edition). E. Braunwald, editor, W. B. Saunders, Philadelphia, PA. 1125-1160.
3. Drexler, H., and A. M. Zeiher. 1991. Endothelial function in human coronary arteries in vivo. Focus on hypercholesterolemia. Hypertension. 18: 1190-99.
4. Drexler, H., A. M. Zeiher, K. Meinzer, and H. Just. 1991. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet. 338: 1546-1550.
5. Zeiher, A. M., H. Drexler, H. Wollschlager, and H. Just, 1991. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 83: 391-401.
6. Grundy, S. M. 1993. Oxidized LDL and atherogenesis: relation to risk factors for coronary heart disease. Clin. Cardiol. 16 (suppl 1): 13-5.
7. Parthasarathy, S., M. T. Quinn, D. C. Schwenke, T. C. Garew, and D. Steinberg. 1989. Oxidative modification of beta-very low density lipoprotein. Potential role in monocyte recruitment and foam cell formation. Arteriosclerosis. 9: 398-404.
8. Ross, R. 1992. The pathogenesis of atherosclerosis. In Heart Disease (4th edition). E. Braunwald, editor. W.B. Saunders, Philadelphia, PA 1106-1124.
9. Goldstein, J. L., Y. K. Ho, S. K. Basu, and M. S. Brown. 1979. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA. 76: 333-337.
10. Heinecke, J. W., H. Rosen, and A. Chait. 1984. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J. Clin. Invest. 74: 1890-1894.
11. Henriksen, T., E. M. Mahoney, and D. Steinberg. 1981. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptor for acetylated low density lipoproteins. Proc. Natl. Acad. Sci. USA. 78: 6499-6503.
12. Morel, D. W., P. E. DiCorleto, and G. M. Chisolm. 1984. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis. 4: 357-364.
13. Parthasarathy, S., D. J. Printz, D. Boyd, L. Joy, and D. Steinberg. 1986. Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor Arteriosclerosis. 6: 505-510.
14. Palinski, W., S. Yla-Herttuala, M. E. Rosenfeld, S. W. Butler, S. A. Socher, S. Parthasarathy, L. K. Curtiss, and J. L. Witztum. 1990. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Atherosclerosis. 10: 325-335.
15. Yla-Herttuala, S., W. Palinski, M. E. Rosenfeld, S. Parthasarathy, T. E. Carew, S. Butler, J. L. Witztum, and D. Steinberg. 1989. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84: 1086-1095.
16. Steinberg, D., S. Parthasarathy, T. E. Carew, J. C. Khoo, and J. L. Witztum. 1989. Beyond cholesterol, modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320: 915-924.
17. Esterbauer, H., G. Jurgens, O. Quehenberger, and E. Koller. 1987. Autooxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J. Lipid Res. 28: 495-509.
18. 2 activity in endothelial cell-induced modification of low density lipoprotein. Proc. Natl. Acad. Sci. USA. 82: 3000-3004.
19. Liao, J. K., W. S. Shin, W. Y. Lee, and S. L. Clark. 1995. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J. Biol. Chem. 270: 319-324.
20. Kugiyama, K., S. A. Kerns, J. D. Morrisett, R. Roberts, and P. D. Henry. 1990. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature, 344: 160-162.
21. Witzum, J. L., and D. Steinberg. 1991. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88: 1785-1792.
22. Murohara, T., K. Kugiyama, M. Ohgushi, S. Sugiyama, Y. Ohta, and H. Yasue. 1994. LPC in oxidized LDL elicits vasocontraction and inhibits endothelium-dependent relaxation. Am. J. Physiol. 267: H2441-H2449.
23. Quinn, M. T., S. Parthasarathy, and D. Steinberg. 1988. Lysophosphatidylcholine: a chemotatic factor for human monocytes and its potential role in atherogenesis. Proc. Natl. Acad. Sci. USA. 85: 2805-2809.
24. Aviram, M. 1989. Modified forms of low density lipoprotein affect platelet aggregation in vitro. Thrombosis Res. 53: 561-567.
25. Kugiyama, K., T. Sakamoto, I. Misumi, S. Sugiyama, M. Ohgushi, H. Ogawa, M. Horiguchi, and H. Yasue. 1993. Transferable lipids in oxidized low-density lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue-type plasminogen activator release from endothelial cells. Circ. Res. 73: 335-343.
26. Ohkawa, H., N. Ohishi, and K. Yagi. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95: 351-358.
27. Liu, S-Y., X. Lu, S. Choy, T. C. Dembinski, G. M. Hatch, D. Mymin, X. Shen, A. Angel, P. C. Choy, and R. Y. K. Man. 1994. Alteration of lysophosphatidylcholine content in low density lipoprotein after oxidative modification: relationship to endothelium dependent relaxation. Cardiovasc. Res. 28: 1476-1481.
28. Yokoyama, M., K. Hirata, R. Miyake, H. Akita, Y. Ishikawa, and H. Fukuzaki. 1990. Lysophosphatidylcholine: essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein. Biochem. Biophys. Res. Commun. 168: 301-308.
29. Hirata, K., M. Nobuhiko, Y. Kuroda, T. Sakoda, S. Kawashima, and M. Yokoyama. 1995. Low concentration of oxidized low-density lipoprotein and lysophosphatidylcholine upregulate constitutive nitric oxide synthase mRNA expression in bovine aortic endothelial cells. Circ. Res. 76: 958-962.
30. Simon, B. C., L. D. Cunningham, and R. A. Cohen. 1990. Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J. Clin. Invest. 86: 75-79.
31. Andrews, H. E., K. R. Bruckdorfer, R. C. Dunn, and M. Jacobs. 1987. Low-density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta. Nature. 327: 237-239.
32. Friedewald, W. T., R. I. Levy, and D. S. Frederickson. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-502.
33. Havel, R. J., H. A. Eder, and J. H. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353.
34. Lowry, O. H., N. J. Roseborough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
35. Bartlett, G. R. 1959. Phosphorus assay in column chromatoeraphy. J. Biol. Chem. 234: 466-468.
36. Tardi, P. G., J. J. Mukherjee, and P. C. Choy. 1992. The quantitation of long chain acyl-CoA in mammalian tissues. Lipids. 27: 65-67.
37. 2 activity of apoprotein B-100. Proc. Natl. Acad. Sci. USA. 87: 9741-9745.
38. White, D. A. 1973. The phospholipid composition in mammalian tissues. In Form and Function of Phospholipids. G. B. Ansell, J. N. Hawthorne, and R. M. C. Dawson, editors. Elsevier/North Holland, Amsterdam. 441-482.
39. Weltzien, H. U. 1979. Cytolytic and membrane-perturbing properties of lysophosphatidylcholine. Biochim. Biophys. Acta. 559: 259-287.